Cubist Systematic Strategies, LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,872,367
-56.7%
49,221
+3.7%
0.01%
-51.7%
Q2 2023$4,325,337
+161.6%
47,479
+89.4%
0.03%
+190.0%
Q1 2023$1,653,551
+73.5%
25,069
+79.7%
0.01%
+100.0%
Q3 2022$953,000
+81.9%
13,951
+35.4%
0.01%
+25.0%
Q1 2022$524,000
-57.8%
10,304
-60.8%
0.00%
-66.7%
Q4 2021$1,243,000
+11.4%
26,297
-22.3%
0.01%
-14.3%
Q3 2021$1,116,000
+168.3%
33,846
+414.1%
0.01%
+180.0%
Q2 2021$416,000
-54.8%
6,584
-69.3%
0.01%
-58.3%
Q1 2021$920,000
+80.0%
21,431
+139.7%
0.01%
+71.4%
Q4 2020$511,000
-42.0%
8,942
-69.4%
0.01%
-46.2%
Q3 2020$881,000
-26.5%
29,208
-20.5%
0.01%
-38.1%
Q2 2020$1,199,000
+71.3%
36,721
+40.6%
0.02%
+10.5%
Q1 2020$700,000
-52.7%
26,124
-45.9%
0.02%
-29.6%
Q4 2019$1,480,000
+231.8%
48,329
+160.8%
0.03%
+200.0%
Q3 2019$446,000
+22200.0%
18,534
+21704.7%
0.01%
Q2 2019$2,000
-99.2%
85
-99.3%
0.00%
-100.0%
Q1 2019$246,000
-20.1%
12,603
-46.0%
0.01%
-46.7%
Q4 2018$308,00023,3510.02%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders